Case report
A 69-year-old man presented with symptoms of severe obstructive uropathy. He had no significant past medical history, was on no regular medication, and smoked 30 cigarettes per day. On urinary catheterisation, he drained 2 litres of urine. Rectal examination revealed an enlarged smooth prostate. His admission blood tests revealed acute renal failure, with a serum creatinine of 1200 µmol/L, improving to 250 µmol/L with conservative management over a four-week period. He underwent a transurethral resection of the prostate (TURP) at this point, under general anaesthesia. General anaesthesia was chosen rather than neuraxial blockade because of possible platelet dysfunction secondary to renal dysfunction. Preoperative blood testing showed haemoglobin (Hb) 9.2 g/dL, Na + 139 mmol/L, K + 4.8 mmol/L, urea 18.9 mmol/L, creatinine 256 µmol/L. Anaesthesia was induced with propofol 2 mg/kg and fentanyl 100 µg. A laryngeal mask airway was inserted, and anaesthesia was maintained with sevoflurane.
The patient remained haemodynamically stable throughout the surgery, and received one litre of crystalloid over the first hour. Warmed 1.5% glycine at a height of 70 cm was used for bladder irrigation. The surgical procedure was difficult and prolonged. Bleeding was noted throughout the procedure, necessitating repeated diathermy to the lateral prostatic wall and catheter traction to achieve haemostasis. An arterial blood gas sample was taken at one hour following initiation of surgical resection. Blood gas analysis revealed profound hyponatraemia and metabolic acidosis, with Na + 92 mmol/L, K + 6.1 mmol/L, pH 7.12, pCO 2 6.2 kPa, pO 2 17.0 kPa, HCO 3 -13 mmol/L, base excess −13 mmol/L, glucose 6.7 mmol/L and lactate 1.2 mmol/L. A combination of blood loss and severe volume overload resulted in a measured Hb concentration of 5.5 g/L. The patient received a transfusion of three units of packed red cells and 40 mg furosemide. At this point his trachea was intubated and he was transferred to the intensive care unit for further management.
On arrival, the patient was breathing spontaneously at a rate of eight breaths per minute. He was sedated using a propofol infusion at 150 mg per hour. A neurological examination demonstrated bilateral fixed, dilated pupils, with no response to painful stimulation. Cardiovascular examination showed a sinus bradycardia of 40 beats per minute. A chest X-ray revealed a normal cardiac shadow with some evidence of pulmonary congestion. The mean arterial blood pressure was 50 mm Hg, and responded well to a short period of inotropic support. Urine output could not be assessed because of continuous bladder irrigation.
Management on the intensive care unit
A cerebral protective strategy was initiated, with 30° head-up tilt, minimal touch, and ventilation to normocapnea using volume-controlled ventilation with 5 cm H 2 O PEEP. Management of acute TUR syndrome included the administration of 30% hypertonic saline at 5 mL/hr (26 mmol/hr) for two hours, prior to the initiation of continuous veno-venous haemofiltration (CVVH) via the femoral vein with 35 mL/kg/hr using Lactasol haemofiltration fluid, in order to achieve correction of electrolyte disturbance, and to manage volume overload with removal of 250 mL fluid per hour for eight hours. The use of haemofiltration enabled achievement of a controlled correction of sodium
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Modern surgical practice and anaesthetic vigilance has reduced the incidence of profound metabolic disturbance associated with absorption of irrigation fluid during endoscopic transurethral resection (TUR) of the prostate. We describe the critical care management of a patient with severe TUR syndrome, who was successfully managed with continuous veno-venous haemofiltration for the treatment of profound electrolyte disturbance, intravascular volume correction, and treatment of irrigation-fluid glycine toxicity. We examine the rationale for rapid and controlled correction of hyponatraemia in TUR syndrome.
Keywords: transurethral resection of prostate; haemofiltration; water-electrolyte imbalance; hyponatraemia concentration (Figure 1) as well as removal of glycine and its breakdown product, ammonia. This therapeutic strategy led to a rapid improvement in clinical state, with return to a full level of orientation twenty hours following the initial insult. He was discharged to the ward the day following admission. He complained of a mild blurring of vision on the day following intensive care discharge, although this had resolved by day two without further treatment. His renal function returned to baseline within one month, with no further neurological or cardiac sequelae.
Discussion
During TURP, venous sinuses are open and irrigation fluid is absorbed into the circulation. Symptomatic sequelae related to the absorption of large quantities of irrigation fluid leads to the TUR syndrome. The reported rate is between 2% and 10%, 1 with a reported mortality of 0.1-0.2%. 2 Irrigation fluid absorption is not easy to control and is related to the duration of surgery, vascularity of the gland, and the pressure at which the irrigation fluid is delivered. Guidelines to minimise the risk of developing TUR syndrome are widely available, although these cannot prevent all cases.
The adoption of osmotically active, non-electrolytecontaining solutions for irrigation, including 1.5% glycine, 0.54% mannitol or 2.7% sorbitol, has led to a significant reduction in morbidity. As some of these fluids are still relatively hypotonic, reduction in plasma osmolarity may still occur following their administration, 3 as may other manifestations of TUR syndrome including hyponatraemia. Further problems caused by these fluids include glycineinduced neurological toxicity including transient blindness or seizures. In addition, metabolic acidosis caused by dilution of strong ions has been reported. 4 Absorption of irrigation fluid is associated with cardiac myocyte swelling, which may result in hypotension and bradycardia following initial hypertension from intravascular volume overload. The cardiovascular system may need vasopressor or inotropic support until this resolves.
Assessment of neurological status for evidence of TUR syndrome is possible during regional anaesthesia, and the onset of confusion or other neurological signs can alert the clinician to the pathological process. A high index of suspicion is warranted during general anaesthesia, with ongoing vigilance of surgical operating time and awareness of difficulty. Signs include changes in haemodynamic parameters including tachycardia and hypertension, with later bradycardia and hypotension. Clinical suspicion should prompt blood gas analysis for measurement of sodium concentration, Hb, and acid-base status. Management includes cessation of bladder irrigation. If regional anaesthesia has been used, then neurological dysfunction may necessitate general anaesthesia for ongoing management.
The available evidence for the management of TUR syndrome suggests that hyponatraemia does not need to be treated aggressively in the absence of clinical complications. The risk of cerebral oedema relates mainly to fluxes in serum osmolarity rather than sodium concentration. Irrigating fluids are osmotically active, although most, including 1.5% glycine, are hypo-osmolar when compared to serum. The use of isoosmolar glycine (2.2%) leads to an increase in glycine toxicity. 5 When these irrigation fluids have been used, TUR syndrome has been associated with a more modest drop in serum osmolarity, and has led to a significant improvement in mortality despite, often, profound hyponatraemia.
The half-life of irrigation fluid solutes is relatively short (between 40 minutes and several hours for glycine) 5 and so the serum osmolarity contributed by the irrigation solute will fall following its metabolism, making timely therapy to correct severe hyponatraemia important. Standard management to improve hyponatraemia includes the infusion of hypertonic saline, which is indicated for symptomatic hyponatraemia or serum levels below 120 mmol/L. Patients with severe acute hyponatraemia are more likely to suffer residual neurological damage or die without this therapy.
Concern that rapid correction of hyponatraemia may precipitate central pontine myelinolysis stems from the experience of the correction of chronic hyponatraemia. Both clinical evidence and experimental evidence in rats has demonstrated that the chronicity of hyponatraemia is crucial in the pathogenesis of central pontine myelinolysis. Hyponatraemia developing within hours and corrected rapidly is associated with fewer brain lesions than is associated with rapid correction of chronic hyponatraemia. This is thought to relate to differences in brain compensatory mechanisms to hyponatraemia; acute onset leads to adaptation with rapidly mobile electrolytes, whereas larger, less mobile, organic osmolytes restore osmotic equilibrium in chronic hyponatremia. 6 Further animal work has demonstrated no change in myelin appearance, but a change in pontine glial cell numbers in rapidly corrected, acute hyponatraemia. 7 Overall, it is advisable to correct severe hyponatraemia promptly to a non-life-threatening level, 8 and then use conservative treatment to restore the residual deficit. No clear rate of correction of acute hyponatraemia has been determined, although 1-1.5 mmol/hr is likely to be a suitable compromise, avoiding neurological sequelae either from overzealous correction or continued hyponatremia. A diuretic can be used to correct symptoms of fluid overload, with careful attention to consequent natriuresis. The use of continuous bladder irrigation postoperatively complicates the monitoring of diuresis. 
Case reports
CVVH for treatment of TUR syndrome
One case series has reported the use of haemofiltration to treat hyponatraemia successfully, 9 and this case report describes haemofiltration for the successful management of severe TUR syndrome. We chose to initiate CVVH as the primary therapy following admission to the intensive care unit. Similar to previous reports of TUR syndrome, the patient described developed a profound metabolic acidosis with severe electrolyte derangement. Haemofiltration was promptly initiated and rapidly improved acid-base status, as well as correcting electrolytes. Furthermore, we were able to use CVVH to accurately adjust fluid balance and remove a controlled amount of free water to reverse volume overload. Accurate management of fluid balance in these patients is critical and is invariably hampered by difficulties monitoring urine output while receiving continuous bladder irrigation.
The patient reported displayed signs of severe glycine toxicity, with fixed dilated pupils and cardiac dysfunction. Although these signs can also be caused by cerebral and myocardial oedema, the rapid resolution following treatment makes a diagnosis of glycine toxicity likely. Although we were unable to obtain plasma glycine levels in this case, severe neurological abnormalities were likely due to this reversible cause. The effective use of haemofiltration to remove glycine and ammonia, its metabolic waste product, is most frequently described in paediatric practice for inborn errors of metabolism. 10 Haemofiltration is an effective method of treatment of severe TUR syndrome and reverses the multiple causes of morbidity safely and effectively. A balance must be struck between the additional risks associated with this invasive form of therapy and the benefits of the additional control it allows. This therapy may be of added benefit in addition to conventional methods when electrolyte disturbance is profound or when volume overload requires rapid but titratable correction, particularly when assessment of urine output is difficult during bladder irrigation, or when coexisting severe renal dysfunction exists.
H yponatraemia is a recognised complication associated with transurethral resection (TUR) of the prostate. The surgical procedure requires the use of large volumes of non-electrolyte containing solutions such as glycine. Glycine solutions are hypo-osmotic with an osmolality of 200 mosmol/kg. The risk of patients developing symptomatic hyponatraemia is related to the rate, volume, osmolality, volume of distribution and the subsequent metabolism or urinary excretion of glycine. Glycine is metabolised to a number of products including serine and ammonia with only 5-10% of glycine being excreted unchanged in the urine. Sodium concentration is the most important determinant of serum osmolality with serum glucose and urea contributing less significantly. Patients developing symptomatic hyponatraemia will initially develop a significant difference in the serum osmolal gap, which is the difference between the measured serum osmolality (which includes glycine) and the estimated serum osmolality based primarily upon the serum sodium. Resolution of this osmolal gap occurs gradually as glycine is metabolised, excreted or absorbed intracellularly. The serum osmolality will therefore gradually fall to that level calculated predominantly from the serum sodium concentration. The expected renal physiological response would be for the excretion of excess water by a maximally dilute urine. However following surgery there is an increased excretion of antidiuretic hormone which impairs this physiological process and prolongs the hyponatraemic state.
Clinical manifestations will be dependent upon the degree of hyponatraemia with more severe hyponatraemia being associated with nausea, vomiting, confusion, visual disturbance, seizures and hypotension. The pathogenesis of these neurological symptoms is poorly understood. It is important to note that the hyponatraemia associated with the absorption of glycine is not associated with a pronounced fall in the measured serum osmolality due to the presence of
